Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells

Doxorubicin is a chemotherapeutic agent indicated for the treatment of a variety of cancer types, including leukaemia, lymphomas, and many solid tumours. The use of doxorubicin is, however, associated with severe cardiotoxicity, often resulting in early discontinuation of the treatment. Importantly,...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmgren, Gustav, Synnergren, Jane, Bogestål, Yalda, Améen, Caroline, Åkesson, Karolina, Holmgren, Sandra, Lindahl, Anders, Sartipy, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326176/
https://www.ncbi.nlm.nih.gov/pubmed/25529476
http://dx.doi.org/10.1016/j.tox.2014.12.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326176/
https://www.ncbi.nlm.nih.gov/pubmed/25529476
http://dx.doi.org/10.1016/j.tox.2014.12.018

Ejemplares similares